TY - JOUR
T1 - E-cigarettes
T2 - Unstandardized, under-regulated, understudied, and unknown health and cancer risks
AU - Hawk, Ernest T.
AU - Maresso, Karen Colbert
N1 - Funding Information:
This work was supported in part by the Boone Pickens Distinguished Chair for Early Prevention of Cancer (to E.T. Hawk) and by the MD Anderson Cancer Center Support Grant 5P30CA016672-37 from the NIH (Bethesda, MD).
Publisher Copyright:
© 2019 American Association for Cancer Research.
PY - 2019/12/15
Y1 - 2019/12/15
N2 - E-cigarettes have the ability to deliver nicotine in a manner that is similar to, and, theoretically, safer than, combusted tobacco. However, these devices are extremely heterogeneous and regulation has struggled to keep up with their rapid evolution. A compilation of early data suggest that e-cigarettes may contain numerous toxic substances, including known carcinogens. However, there are few data available on the short- and long-term health effects of e-cigarettes, including any potential effect on cancer risk. Until more is known, e-cigarettes should not be considered a safe alternative to combusted tobacco use.
AB - E-cigarettes have the ability to deliver nicotine in a manner that is similar to, and, theoretically, safer than, combusted tobacco. However, these devices are extremely heterogeneous and regulation has struggled to keep up with their rapid evolution. A compilation of early data suggest that e-cigarettes may contain numerous toxic substances, including known carcinogens. However, there are few data available on the short- and long-term health effects of e-cigarettes, including any potential effect on cancer risk. Until more is known, e-cigarettes should not be considered a safe alternative to combusted tobacco use.
UR - http://www.scopus.com/inward/record.url?scp=85076403128&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076403128&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-19-2997
DO - 10.1158/0008-5472.CAN-19-2997
M3 - Article
C2 - 31658978
AN - SCOPUS:85076403128
SN - 0008-5472
VL - 79
SP - 6079
EP - 6083
JO - Cancer Research
JF - Cancer Research
IS - 24
ER -